MagForce AG (BST:MF6)

Germany flag Germany · Delayed Price · Currency is EUR
0.0060
-0.0015 (-20.00%)
At close: Feb 26, 2026
Market Cap183.44K +500.0%
Revenue (ttm)1.08M -28.3%
Net Income-10.57M
EPS-0.35
Shares Out30.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,200
Average Volume53,772
Open0.0075
Previous Close0.0075
Day's Range0.0060 - 0.0080
52-Week Range0.0005 - 0.0180
Beta-11.00
RSI53.62
Earnings Daten/a

About MagForce AG

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Employees 33
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol MF6
Full Company Profile

Financial Performance

Financial Statements